What is the specificity of the response to the own first-name when presented as a novel in a passive oddball paradigm? An ERP study

Brain Research
Jean-Baptiste EichenlaubDominique Morlet

Abstract

One's own first-name is a special stimulus: one's attention is more likely captured by hearing one's own first-name than by hearing another first-name. Previous event-related potential (ERP) studies demonstrated that this special stimulus produces differential responses both in active and in passive condition. Such results suggest that passively hearing one's own first-name triggers processing levels generally activated by the explicit detection of stimuli. This questions about the particular power of the own first-name to automatically orient attention, but no study investigated the specific response to this special stimulus in a paradigm designed to study automatic attention orienting. In this ERP study, we compared the responses elicited by the own first-name (OWN) and one unfamiliar first-name (OTHER) presented, rarely, randomly and at the same frequency among repetitive tones (i.e., as novel stimuli in an oddball paradigm) while subjects (N=36) were watching a silent movie with subtitles. We tested at what latency the responses to OWN and OTHER diverge, and whether OWN modulates the brain orienting response (novelty P3). Data analysis showed specific responses to OWN after 300 ms. OWN only evoked a central negativity (320 ...Continue Reading

References

Mar 1, 1991·Psychophysiology·D Guthrie, J S Buchwald
Apr 1, 1988·Electroencephalography and Clinical Neurophysiology·J PernierO Bertrand
Feb 1, 1989·Electroencephalography and Clinical Neurophysiology·F PerrinJ F Echallier
Apr 1, 1987·IEEE Transactions on Bio-medical Engineering·F PerrinJ Pernier
Dec 1, 1985·Perceptual and Motor Skills·D T Shek, J A Spinks
Nov 26, 1965·Science·S SuttonE R John
Sep 1, 1995·Electroencephalography and Clinical Neurophysiology·I Berlad, H Pratt
Feb 1, 1997·Brain and Language·R L Folmer, C D Yingling
Mar 1, 1997·Journal of Sleep Research·T H MonkD J Kupfer
Dec 6, 1997·Neuroscience Letters·A MecklingerA D Friederici
Aug 26, 1998·Psychophysiology·D FriedmanY M Cycowicz
Nov 6, 1998·Journal of Cognitive Neuroscience·C EsceraR Näätänen
Apr 24, 1999·Psychiatry and Clinical Neurosciences·H NinomiyaN Tashiro
May 29, 1999·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·H PrattP Lavie
Jan 1, 2000·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·F PerrinH Bastuji
Jul 11, 2001·Neuroscience and Biobehavioral Reviews·D FriedmanH Gaeta
Oct 12, 2001·Neuroscience and Biobehavioral Reviews·C S Herrmann, R T Knight
Nov 13, 2001·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·K MarinkovicI Maltzman
Mar 4, 2003·Nature Reviews. Neuroscience·Charan Ranganath, Gregor Rainer
Mar 26, 2003·The European Journal of Neuroscience·Stefan Berti, Erich Schröger
Apr 23, 2003·Brain Research. Cognitive Brain Research·Elena YagoJosep M Serra-Grabulosa
Nov 19, 2003·The European Journal of Neuroscience·Carles EsceraM Isabel Nuñez
Mar 3, 2006·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·John Polich, José R Criado
May 17, 2006·Brain Research·Irena HoleckovaDominique Morlet
Jun 19, 2007·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·John Polich
Jun 19, 2007·The European Journal of Neuroscience·Elena KushnerenkoMinna Huotilainen
Jul 20, 2007·The European Journal of Neuroscience·Anja RoyeErich Schröger
Dec 7, 2007·Brain Research·Irena HoleckovaFrançois Mauguière
Apr 29, 2008·Biological Psychology·Johanna KisslerMarkus Junghofer
Jun 11, 2008·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Marjo J R Brinkman, Johannes E A Stauder
Sep 2, 2008·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Catherine FischerDominique Morlet
Sep 12, 2008·The European Journal of Neuroscience·Judith Domínguez-BorràsCarles Escera
Nov 13, 2008·Neurology·C SchnakersS Laureys
Oct 22, 2009·BMC Neuroscience·Ian CharestPascal Belin

❮ Previous
Next ❯

Citations

Nov 22, 2013·PloS One·Perrine RubyAurélie Bidet-Caulet
Nov 28, 2013·Brain Topography·Dominique Morlet, Catherine Fischer
Aug 4, 2015·Biological Psychology·Tatiana CondeAna P Pinheiro
Jun 21, 2015·International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology·Nicole Wetzel
May 7, 2015·Cognitive Neuroscience·Glyn W Humphreys, Jie Sui
Nov 13, 2013·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Sibylle Bertoli, Daniel Bodmer
Jul 28, 2016·Biological Psychology·Alexandra P KeySarika U Peters
Aug 28, 2014·Neurorehabilitation and Neural Repair·Caroline SchnakersSteven Laureys
Feb 20, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jean-Baptiste EichenlaubPerrine Ruby
Sep 18, 2015·Neuroreport·Ran LiGuixiang Shan
Oct 7, 2017·Frontiers in Neuroinformatics·Etienne CombrissonKarim Jerbi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.